Text Size

Community-Effectiveness of the Distribution of Insecticide-Treated Bed Nets Through Social Marketing Antenatal Care Services in Malaria Control in Rural Burkina Faso

This study has been completed.
Sponsor:
Information provided by:
University of Heidelberg
ClinicalTrials.gov Identifier:
NCT00355225
First received: July 19, 2006
Last updated: October 6, 2006
Last verified: July 2006
History of Changes
  Purpose

The study aims at assessing which of two distribution channels for insecticide treated bendnets (ITNs), social marketing vs. social marketing coupled with free distribution through ante-natal care, is most effective in reaching groups at high risk of malaria, i.e. pregnant women and children under 5.


Condition Intervention
Malaria
 Procedure: ITN distribution channel

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training

Resource links provided by NLM:

MedlinePlus related topics: Malaria
U.S. FDA Resources

Further study details as provided by University of Heidelberg:

Primary Outcome Measures:
  • ITN coverage in households 12 and 24 months after the start of the interventions
  • ITN use during pregnancy and infancy

Secondary Outcome Measures:
  • Costs per malaria case and per DALY prevented
  • Self-reported information on ANC visits
  • Insecticide content on ITN and mortality of vector mosquitoes over time
  • Acceptance of health staff and population

Detailed Description:

The hypothesis that insecticide-treated bed net (ITN) effects may not be long-lasting in young children living in areas of intense malaria transmission due to interactions with the immunologi-cal development has now been refuted in a number of studies including the D4 study. The highly controversial question remains how African programmes can best reach a sustainable high coverage with ITNs in young children and pregnant women. Against this background it is planned to implement a cluster randomised controlled trial in Nouna Health District in Burkina Faso. Twenty-two peripheral health centres and their catchment areas will be randomised to (1) ITN provision to the general population through social marketing and (2) ITN provision to the general population through social marketing plus free provision to all pregnant women through antenatal services. The primary outcomes are ITN coverage in households and ITN use during pregnancy and infancy.

  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Being one of 25 primary health facility catchment areas in the Nouna Health District, Burkina Faso

Exclusion Criteria:

  • Being outside one of 25 primary health facility catchment areas in the Nouna Health District, Burkina Faso
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00355225

Sponsors and Collaborators
University of Heidelberg
Investigators
Principal Investigator: Olaf Mueller, MD, MPH University of Heidelberg
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00355225     History of Changes
Other Study ID Numbers: SFB544D4
Study First Received: July 19, 2006
Last Updated: October 6, 2006
Health Authority: Germany: Ethics Commission

Keywords provided by University of Heidelberg:
insecticide-treated bednets
malaria
africa
social marketing
 ante-natal care
ITN coverage
ITn use

Additional relevant MeSH terms:
Malaria
Protozoan Infections
Parasitic Diseases

ClinicalTrials.gov processed this record on June 17, 2013